← Insider buys
AKRO

Akero Therapeutics, Inc. · HEALTHCARE

Versant Venture Capital Vi, L.P. sold $1.1M of Akero Therapeutics, Inc.

10% owner

Sold$1,060,845
$19.99Price
53,057Shares
−2%Stake

What AKRO did after the filing

Prices for AKRO after this filing aren't in yet.

Traded Tue, Jan 7. Filed Fri, Jul 10. Not investment advice.